| Literature DB >> 1666184 |
K Kohara1, Y Tabuchi, P Senanayake, K B Brosnihan, C M Ferrario.
Abstract
Characterization of C- and N-terminal forms of angiotensin (Ang) peptides mandated assessment of methods to determine plasma levels. 125I-Ang I, 125I-Ang II, and 125I-Ang(1-7) were added to blood samples in the presence of protease inhibitors. Ethylenediaminetetraacetic acid (EDTA) inhibited the conversion of 125I-Ang I to 125I-Ang II. o-Phenanthroline and EDTA (EDTA + o-Ph) did not eliminate [des-Asp1] fragments or 125I-Ang(1-7). The combination of EDTA + o-Ph and pepstatin A or 4-(chloromercuri) benzoic acid (PCMB) significantly reduced 125I-Ang(1-7) generation. Only PCMB plus EDTA + o-Ph eliminated [des-Asp1] fragments. Authentic plasma values of Ang peptides require the correct choice of protease inhibitors.Entities:
Mesh:
Substances:
Year: 1991 PMID: 1666184 DOI: 10.1016/0196-9781(91)90070-6
Source DB: PubMed Journal: Peptides ISSN: 0196-9781 Impact factor: 3.750